The authors regret that there was an error in the labelling of plasmid K78I. All the cell lines containing mutant LKB1 should be labelled K78I, not K78M, throughout this article.
The authors would like to apologise for any inconvenience caused.
. Author manuscript; available in PMC: 2021 Apr 8.
Published in final edited form as: Lung Cancer. 2021 Feb 19;154:228. doi: 10.1016/j.lungcan.2021.02.013
Corrigendum to “Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression” [Lung Cancer 88/2 (2015) 131–138]
Kaisheng Mao
a,b,c, Fakeng Liu
a,d, Xiuju Liu
a, Fadlo R Khuri
a, Adam I Marcus
a, Mingsong Li
c,**, Wei Zhou
a,*
Kaisheng Mao
aThe Winship Cancer Institute, Emory University School of
Medicine, Atlanta, GA 32322, United States
bDepartment of Hepatobiliary Surgery, NanFang Hospital,
Guangzhou, People’s Republic of China
cDepartment of Gastroenterology, NanFang Hospital,
Guangzhou, People’s Republic of China
Find articles by Kaisheng Mao
Fakeng Liu
aThe Winship Cancer Institute, Emory University School of
Medicine, Atlanta, GA 32322, United States
dDepartment of Gastrointestinal Surgery, The First
Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic
of China
Find articles by Fakeng Liu
Xiuju Liu
aThe Winship Cancer Institute, Emory University School of
Medicine, Atlanta, GA 32322, United States
Find articles by Xiuju Liu
Fadlo R Khuri
aThe Winship Cancer Institute, Emory University School of
Medicine, Atlanta, GA 32322, United States
Find articles by Fadlo R Khuri
Adam I Marcus
aThe Winship Cancer Institute, Emory University School of
Medicine, Atlanta, GA 32322, United States
Find articles by Adam I Marcus
Mingsong Li
cDepartment of Gastroenterology, NanFang Hospital,
Guangzhou, People’s Republic of China
Find articles by Mingsong Li
Wei Zhou
aThe Winship Cancer Institute, Emory University School of
Medicine, Atlanta, GA 32322, United States
Find articles by Wei Zhou
aThe Winship Cancer Institute, Emory University School of
Medicine, Atlanta, GA 32322, United States
bDepartment of Hepatobiliary Surgery, NanFang Hospital,
Guangzhou, People’s Republic of China
cDepartment of Gastroenterology, NanFang Hospital,
Guangzhou, People’s Republic of China
dDepartment of Gastrointestinal Surgery, The First
Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic
of China
*
Corresponding author at: Department of Hematology and Medical Oncology, Emory University School of Medicine, Building C, Room 4084, 1365 Clifton Rd, NE, Atlanta, GA, 30307, United States. wzhou2@emory.edu (W. Zhou).
**
Corresponding author at: Department of Gastroenterology, NanFang Hospital, Southern Medical University, No. 1838, Northern Guangzhou Avenue, Guangzhou, Guangdong, 510515, People’s Republic of China. lims@smu.edu.cn (M. Li)
Issue date 2021 Apr.
PMCID: PMC8026713 NIHMSID: NIHMS1684573 PMID: 33618911
The publisher's version of this article is available at Lung Cancer
This corrects the article "Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression" in volume 88 on page 131.